Cathie Wood's position in Beam Therapeutics is currently worth $398M. That's 2.66% of their equity portfolio (11th largest holding). The investor owns 11.76% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares fourteen more times and sold shares on seven occasions. The investor's estimated purchase price is $669M, resulting in a loss of 40%.